CoChat

Increased stiffness of the tumor microenvironment in colon cancer stimulates cancer associated fibroblast-mediated prometastatic activin A signaling

Open access
Bauer, Jessica, Emon, Md Abul Bashar, Staudacher, Jonas J., Thomas, Alexandra L., Zessner-Spitzenberg, Jasmin, Mancinelli, Georgina, Krett, Nancy, Saif, M. Taher, Jung, Barbara · 2020 · Scientific Reports

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Colorectal cancer (CRC) is the second deadliest cancer in the US due to its propensity to metastasize. Stromal cells and especially cancer-associated fibroblasts (CAF) play a critical biophysical role in cancer progression, but the precise pro-metastatic mechanisms are not clear. Activin A, a TGF-β family member, is a strong pro-metastatic cytokine in the context of CRC. Here, we assessed the link between biophysical forces and pro-metastatic signaling by testing the hypothesis that CAF-generated mechanical forces lead to activin A release and associated downstream effects. Consistent with our hypothesis, we first determined that stromal activin A secretion increased with increasing substrate stiffness. Then we found that stromally-secreted activin A induced ligand-dependent CRC epithelial cell migration and epithelial to mesenchymal transition (EMT). In addition, serum activin A levels are significantly increased in metastatic (stage IV) CRC patients (1.558 ng/ml versus 0.4179 ng/ml, p < 0.05). We propose that increased tumor microenvironment stiffness leads to stromal cell-mediated TGF-β family signaling relying on the induction and utilization of activin A signaling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-019-55687-6

Cites

Statistics

Figures

Figure 1 Activin A secretion from fibroblasts increases with higher substrate stiffness and induces epithelial cell migration. (a) ELISA measuring secreted activin A from CCD18 fibroblast cells cultured on substrates with increasing stiffness. (b) Migration of FET epithelial cells through a transwell following treatment with media collected from CCD18 cells cultured on substrates with increasing stiffness. To demonstrate the specific impact of activin A on cell migration, cells were treated with follistatin (F), an inhibitor of activin A, 30 minutes prior to sample collection. (c) Representative pictures of DAPI stained cells of migrated FET from (b) treated with TGF-β (T) on the left panel and follistatin (F) 30 min prior TGF-β (T) treatment on the right panel. (d) ELISA measuring activin A level secreted from CCD18 fibroblasts cultured on 10kPa substrate. To demonstrate the influence of cell attachment on activin secretion, we treated CCD18 with RGDS peptide (R) prior to TGF-β (T) treatment to disrupt cell attachment via integrins. For Fig. 1, all the cells were treated with TGF-β (T) for 72 hours to induce CAF phenotype and lead to activin A secretion. (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).
Figure 1 Activin A secretion from fibroblasts increases with higher substrate stiffness and induces epithelial cell migration. (a) ELISA measuring secreted activin A from CCD18 fibroblast cells cultured on substrates with increasing stiffness. (b) Migration of FET epithelial cells through a transwell following treatment with media collected from CCD18 cells cultured on substrates with increasing stiffness. To demonstrate the specific impact of activin A on cell migration, cells were treated with follistatin (F), an inhibitor of activin A, 30 minutes prior to sample collection. (c) Representative pictures of DAPI stained cells of migrated FET from (b) treated with TGF-β (T) on the left panel and follistatin (F) 30 min prior TGF-β (T) treatment on the right panel. (d) ELISA measuring activin A level secreted from CCD18 fibroblasts cultured on 10kPa substrate. To demonstrate the influence of cell attachment on activin secretion, we treated CCD18 with RGDS peptide (R) prior to TGF-β (T) treatment to disrupt cell attachment via integrins. For Fig. 1, all the cells were treated with TGF-β (T) for 72 hours to induce CAF phenotype and lead to activin A secretion. (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).CC BY · PubMed Central
Figure 2 Displacement field and traction map of CCD18 cells on substrates of varying stiffness. (a–c) Presents Traction Force Microscopy (TFM) results with CCD18 cells on 2, 5 and 40 kPa substrates respectively. Each image shows substrate displacement vectors and traction stress maps. Cell boundaries are outlined in yellow. Cell spreading area and traction stress increases with increasing stiffness. As a result, total force also increases. However, average substrate deformation remains close for all the substrates. The color scale varies from smaller values for violet to higher values for red. Unit for displacement is pixels (1 pixel = 167 nm) and unit for traction map is Pa.
Figure 2 Displacement field and traction map of CCD18 cells on substrates of varying stiffness. (a–c) Presents Traction Force Microscopy (TFM) results with CCD18 cells on 2, 5 and 40 kPa substrates respectively. Each image shows substrate displacement vectors and traction stress maps. Cell boundaries are outlined in yellow. Cell spreading area and traction stress increases with increasing stiffness. As a result, total force also increases. However, average substrate deformation remains close for all the substrates. The color scale varies from smaller values for violet to higher values for red. Unit for displacement is pixels (1 pixel = 167 nm) and unit for traction map is Pa.CC BY · PubMed Central
Figure 3 Immunoblot of changes in Snail and E-Cadherin expression. TGF-β and stromal cell conditioned media leads to an increase in EMT-associated activin A signaling in stromal and epithelial cells. (b) Densitometry of 3 independent immunoblot replicates normalized to the GAPDH control. Immunoblot of Snail expression in CRC cells (FET) following treatment with TGF-β, follistatin (F), conditioned media (CM) from CCD18 stromal cells, or Conditioned Media (CM) with follistatin (F). Follistatin (F) treatment was used to demonstrate the influence of activin A specifically on Snail expression. (c) Densitometry of 3 independent immunoblot of E-Cadherin protein expression replicates normalized to the beta-actin control. (*p < 0.05).
Figure 3 Immunoblot of changes in Snail and E-Cadherin expression. TGF-β and stromal cell conditioned media leads to an increase in EMT-associated activin A signaling in stromal and epithelial cells. (b) Densitometry of 3 independent immunoblot replicates normalized to the GAPDH control. Immunoblot of Snail expression in CRC cells (FET) following treatment with TGF-β, follistatin (F), conditioned media (CM) from CCD18 stromal cells, or Conditioned Media (CM) with follistatin (F). Follistatin (F) treatment was used to demonstrate the influence of activin A specifically on Snail expression. (c) Densitometry of 3 independent immunoblot of E-Cadherin protein expression replicates normalized to the beta-actin control. (*p < 0.05).CC BY · PubMed Central
Figure 4 Activin A serum levels are predictive for CRC metastasis. (a) ELISA measuring activin A concentration from a cohort of 28 polyp free controls and 28 colon cancer cases. Each stage containing 7 patients. (b) A comparison of activin A serum concentration in colon cancer cases stratified by cancer stage. (*p < 0.05). (c) comparison of activin A serum concentration in colon cancer patients with metastatic disease (M1) and patients without metastasis (M0). (d) ROC analysis to demonstrate the potential of activin A as a predictive indicator for metastasis in CRC. (*p < 0.05).
Figure 4 Activin A serum levels are predictive for CRC metastasis. (a) ELISA measuring activin A concentration from a cohort of 28 polyp free controls and 28 colon cancer cases. Each stage containing 7 patients. (b) A comparison of activin A serum concentration in colon cancer cases stratified by cancer stage. (*p < 0.05). (c) comparison of activin A serum concentration in colon cancer patients with metastatic disease (M1) and patients without metastasis (M0). (d) ROC analysis to demonstrate the potential of activin A as a predictive indicator for metastasis in CRC. (*p < 0.05).CC BY · PubMed Central
Figure 5 Cancer associated fibroblasts release activin A cultured on intermediate stiffness and leads to cell migration and EMT. TGF-β activates colon stromal fibroblast into cancer associated fibroblasts which secrete activin A. This secretion is enhanced through increased stromal stiffness. The highest level of activin A is released in an intermediate stiffness environment. The increase in activin A can induce migration in colon epithelial cells and lead to EMT resulting in a more metastatic phenotype. Follistatin can counteract this effect. Also the integrin-ligand inhibited through RGDS requires activin A.
Figure 5 Cancer associated fibroblasts release activin A cultured on intermediate stiffness and leads to cell migration and EMT. TGF-β activates colon stromal fibroblast into cancer associated fibroblasts which secrete activin A. This secretion is enhanced through increased stromal stiffness. The highest level of activin A is released in an intermediate stiffness environment. The increase in activin A can induce migration in colon epithelial cells and lead to EMT resulting in a more metastatic phenotype. Follistatin can counteract this effect. Also the integrin-ligand inhibited through RGDS requires activin A.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 70 · Cited by 133

Research works printed but not linked: 1

  1. Lin, J. S. et al. In Screening for Colorectal Cancer: A Systematic Review for the U.S. Preventive Services Task Force U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews (2016).

Metadata

Authors
Bauer, J., Emon, M. A. B., Staudacher, J. J., Thomas, A. L., Zessner-Spitzenberg, J., Mancinelli, G., Krett, N., Saif, M. T., & Jung, B.
Affiliations
  • University of Illinois Chicago (US)
  • Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
  • University of Illinois Urbana-Champaign (US)
Corresponding author
Jung, Barbara
Venue
Scientific Reports
Published
2020-01-09
Volume
10
Issue
1
Pages
50-50
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2999599692
Cited by
133
References
70
Citations by year
2026: 9 · 2025: 20 · 2024: 21 · 2023: 26 · 2022: 20 · 2021: 24 · 2020: 13
FWCI
10.47
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • NSF | National Science Board (CMMI 17- 42908)
  • U.S. Department of Health & Human Services | National Institutes of Health (RO1 CA141057)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
colorectal cancer, cancer-associated fibroblasts, activin A, mechanotransduction, TGF-beta signaling, epithelial-mesenchymal transition, epithelial cell migration, metastasis, stromal cells
MeSH terms
Snail Family Transcription Factors, Cancer-Associated Fibroblasts, Aged, Aged, 80 and over, Cell Movement, Female, Humans, Male, Middle Aged, Neoplasm Metastasis, Neoplasm Staging, Colorectal Neoplasms, Signal Transduction, Cadherins, Case-Control Studies, Transforming Growth Factor beta, Activins, Cell Line, Tumor, Epithelial-Mesenchymal Transition, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased stiffness of the tumor microenvironment in colon cancer stimulates cancer associated fibroblast-mediated prometastatic activin A signaling. https://app.cochat.ai/papers/10.1038/s41598-019-55687-6
The paper
Bauer, J., Emon, M. A. B., Staudacher, J. J., Thomas, A. L., Zessner-Spitzenberg, J., Mancinelli, G., Krett, N., Saif, M. T., & Jung, B. (2020). Increased stiffness of the tumor microenvironment in colon cancer stimulates cancer associated fibroblast-mediated prometastatic activin A signaling. Scientific Reports. https://doi.org/10.1038/s41598-019-55687-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.